Patents by Inventor Jeevan Ghosalkar

Jeevan Ghosalkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BEZAFIBRATE FOR THE TREATMENT OF CANCER
    Publication number: 20180021276
    Abstract: Methods of treating renal cancer, including renal cell carcinoma, using bezafibrate are disclosed herein. Bezafibrate can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.
    Type: Application
    Filed: July 19, 2017
    Publication date: January 25, 2018
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • Methazolamide for the treatment of cancer
    Publication number: 20180021313
    Abstract: The present invention relates to methods of using methazolamide to treat pancreatic cancer. Pancreatic cancer can be treated by administering to a patient in need thereof an effective amount of methazolamide, optionally in combination with one or more additional cancer therapies.
    Type: Application
    Filed: July 17, 2017
    Publication date: January 25, 2018
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • Mesalamine for the treatment of cancer
    Patent number: 9867865
    Abstract: Methods of treating renal cancer, including renal cell carcinoma, using mesalamine are disclosed herein. Mesalamine can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.
    Type: Grant
    Filed: June 29, 2017
    Date of Patent: January 16, 2018
    Assignee: Cipla Limited
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • MESALAMINE FOR THE TREATMENT OF CANCER
    Publication number: 20180000894
    Abstract: Methods of treating renal cancer, including renal cell carcinoma, using mesalamine are disclosed herein. Mesalamine can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.
    Type: Application
    Filed: June 29, 2017
    Publication date: January 4, 2018
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • PAR-4 AGONISTS FOR THE TREATMENT OF CANCER
    Publication number: 20170368072
    Abstract: Disclosed herein are methods of treating cancers by administration of a PAR-4 agonist.
    Type: Application
    Filed: June 28, 2017
    Publication date: December 28, 2017
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20170232020
    Abstract: An oral or injectable pharmaceutical composition is provided for treating diseases caused by retroviruses or hepatitis B viruses. The composition comprises a therapeutically effective amount of at least one anti-retroviral drug and a therapeutically effective amount of at least one pharmacokinetic booster or enhancer or derivative thereof. Methods and kits are also provided.
    Type: Application
    Filed: February 1, 2017
    Publication date: August 17, 2017
    Inventors: Geena Malhotra, Kalpana Joshi, Jeevan Ghosalkar, Preeti Raut
  • METHOD OF TREATING PULMONARY ARTERIAL HYPERTENSION
    Publication number: 20170035765
    Abstract: The present invention is concerned with the treatment of Pulmonary Arterial Hypertension (PAH) by administering Paliperidone. The instant invention further relates to use of a pharmaceutical composition comprising Paliperidone, for the treatment of PAH.
    Type: Application
    Filed: August 8, 2016
    Publication date: February 9, 2017
    Inventors: Karl Roberts, Geena Malhotra, Dhiraj Abhyankar, Kalpana Joshi, Jeevan Ghosalkar
  • THIENOPYRIDINE DERIVATIVE FOR THE TREATMENT OF HEPATITIS C INFECTIONS
    Publication number: 20170014394
    Abstract: The present invention relates to methods of treatment of hepatitis C using prasugrel. The methods of the present invention can be used in patients with hepatitis C administering prasugrel in combination with one or more anti-hepatitis C drugs.
    Type: Application
    Filed: July 18, 2016
    Publication date: January 19, 2017
    Inventors: Karl Roberts, Geena Malhotra, Dhiraj Abhyankar, Kalpana Joshi, Jeevan Ghosalkar